.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Medtronic
Cerilliant
QuintilesIMS
Teva
McKinsey
US Army
Julphar
AstraZeneca
Farmers Insurance

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201832

« Back to Dashboard
NDA 201832 describes NIMODIPINE, which is a drug marketed by Thepharmanetwork Llc, Heritage Pharms Inc, Sofgen Pharms, Bionpharma Inc, and Sun Pharm Inds Inc, and is included in five NDAs. It is available from nine suppliers. Additional details are available on the NIMODIPINE profile page.

The generic ingredient in NIMODIPINE is nimodipine. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nimodipine profile page.

Summary for NDA: 201832

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 201832

Ingredient-typeDihydropyridines
Mechanism of ActionCalcium Channel Antagonists

Suppliers and Packaging for NDA: 201832

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NIMODIPINE
nimodipine
CAPSULE;ORAL 201832 ANDA ANI Pharmaceuticals, Inc. 62559-210 62559-210-31 30 CAPSULE in 1 CARTON (62559-210-31)
NIMODIPINE
nimodipine
CAPSULE;ORAL 201832 ANDA ANI Pharmaceuticals, Inc. 62559-210 62559-210-52 10 CAPSULE in 1 BLISTER PACK (62559-210-52)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength30MG
Approval Date:Jul 24, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Covington
Medtronic
Queensland Health
Novartis
Express Scripts
Argus Health
Chubb
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot